Pricing and reimbursement
AIFA intervenes in the governance of pharmaceutical expenditure by negotiating the price of medicinal products and managing the National Pharmaceutical Formulary (PFN).
In addition, AIFA monitors the appropriateness of use of medicines through the development, management and analysis of registers and consumption data.
It periodically reviews the Notes, which are regulatory tools that define the eligibility for reimbursement of some medicinal products and are updated on the basis of new scientific evidence and the needs of daily medical practice on the national territory.
Every month, the Agency also publishes the updated transparency lists, which are the lists of medicinal products whose patent coverage has expired, with the relative reference prices.
01/09/2015
13/08/2015
04/08/2015
31/07/2015
30/07/2015
15/07/2015
03/07/2015
25/06/2015
17/06/2015
15/06/2015
12/06/2015
10/06/2015
28/05/2015
21/05/2015
18/05/2015
15/05/2015
13/05/2015
05/05/2015
28/04/2015
16/04/2015
15/04/2015
13/04/2015
08/04/2015
01/04/2015
25/03/2015
16/03/2015